Genus shares soar on US regulatory approval for gene edited pigs
US FDA approves gene edited pigs Decision de-risks approval in other territories Potential to triple operating profit Shares in leading global animal genetics company Genus (GNS) surged as much as 395p or 24% to £19.80 on...
30 April 2025